I

iBio
D

IBIO

0.74000
USD
0.01
(0.68%)
مغلق
حجم التداول
13,969
الربح لكل سهم
-2
العائد الربحي
-
P/E
-19
حجم السوق
12,002,268
أصول ذات صلة
A
ALT
-0.14000
(-2.86%)
4.75000 USD
A
AMRN
0.025
(0.15%)
16.665 USD
A
AXSM
1.415
(1.36%)
105.335 USD
E
EVOK
-0.16000
(-6.02%)
2.50000 USD
I
INO
-0.71500
(-33.49%)
1.42000 USD
T
TTNP
0.07000
(1.65%)
4.32000 USD
V
VSTM
-0.05500
(-1.13%)
4.81500 USD
X
XENE
-0.130
(-0.39%)
33.250 USD
المزيد
الأخبار المقالات

العنوان: iBio

القطاع: Healthcare
الصناعة: Biotechnology
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.